Introduction
Hypoxemia occurs in most patients during hemodialysis when the dialysate contains acetate (1, 2) . Two major hypotheses have Received for publication 27 June 1983 and in revised form 4 January 1984. been advanced to explain such hypoxemia. Since some carbon dioxide diffuses out of the blood passing across the dialysis membrane, a normal arterial partial pressure of CO2 (PaCO2)' may be maintained with less CO2 removal by pulmonary ventilation (3, 4) . Hypoxemia, then, may be a direct result of diminished alveolar ventilation (3) (4) (5) (6) . A second explanation for hypoxemia suggests that the pulmonary leukocyte aggregation caused by complement activation on the dialysis membrane interferes with ventilation-perfusion matching in the lung (2, 7, 8) . Aggregated leukocytes may mechanically alter blood flow or release toxic products that alter ventilation-perfusion matching (8) (9) (10) .
Several previous studies have supported one or the other of these mechanisms. Many reports, however, have suffered from imprecision because not all multiple variables that affect gas exchange have been measured directly. We have applied the multiple inert gas elimination technique as a means to quantitate pulmonary gas exchange during dialysis. This method is independent of carbon dioxide and oxygen flux across the dialysis membrane. With this technique, small quantities of six inert gases with widely different solubilities are infused intravenously; resulting concentrations are measured in arterial blood, mixed venous blood, and exhaled air. Since the gases have different solubilities, their concentrations in the blood and gas phase are sensitive indicators of ventilation-perfusion matching. These measurements allow calculation ofpulmonary shunt, dead space, and the degree of ventilation-perfusion (alveolar ventilation-to perfusion ratio [VA/QI) heterogeneity. Our results reveal no evidence of ventilation-perfusion mismatching during hemodialysis when ventilation is mechanically maintained at a constant rate.
Methods
9 mongrel dogs weighing 20-24 kg were anesthetized with thiopental sodium (20-30 mg/kg), intubated with a cuffed endotracheal tube, and mechanically ventilated with room air at a tidal volume of 15 ml/kg and at a rate sufficient to maintain an arterial Paco2 of 32-36 torr. Thereafter, ventilation was kept at a constant minute volume. Subsequent 1. Abbreviations used in this paper: (a-A)D; inert gas arterial-alveolar difference; PaCO2, arterial partial pressure of C02; R, lung respiratory exchange ratio (Vco2/Vo2); QS/QT, shunt fraction; VA/Q, alveolar ventilation-to-perfusion ratio; Vco2, CO2 elimination; Vo2, oxygen consumption; VD/VT, dead space to tidal volume ratio; WBC, white blood cell.
anesthesia and paralysis were maintained with intravenous pentobarbital (60 mg) and pancuronium (20 mg) given slowly every 30-60 min as needed to prevent spontaneous ventilation. Neither medication was given within the 10 min before any sampling time. Catheters were introduced into one femoral vein for the infusion of the inert gas mixture and into the ipsilateral femoral artery for pressure monitoring and arterial blood sample collection. The contralateral femoral artery and vein were cannulated for hemodialysis. A Swan-Ganz thermodilution pulmonary artery catheter (Edwards Laboratories, American Hospital Supply Corp., Santa Ana, CA) was inserted via a jugular vein into the pulmonary artery for pressure monitoring and collection of mixed venous blood samples. Exhaled respiratory gas was passed through a 6-liter mixing chamber before sampling.
To avoid excessive hypotension during dialysis, 200-300 ml normal saline was infused before control measurements were obtained. A solution of six inert gases (sulfur hexafluoride, ethane, cyclopropane, halothane, diethyl ether, and acetone) in 5% dextrose in water was infused through a peripheral vein at a rate of 3 ml/min starting at least 30 min before the first set of studies. When hemodynamic parameters were stable for at least 15 min after the saline infusion, the control set of hemodynamic measurements and blood and exhaled gas samples were obtained (time 0). Hemodialysis was then performed for 2 h against a standard acetatecontaining dialysate. The dialyzers had a cuprophane membrane with surface area of 0.54-1.0 m2. Blood flow was 90-175 ml/min through the dialyzer. In each individual dog, flow varied by <25 ml/min during the experiment. Repeat hemodynamic measurements and sample collections were obtained after 5, 15, 30, 60, and 120 min of dialysis. Blood in the dialyzer was returned to the dog at the conclusion of dialysis and a final set of measurements and samples was obtained at 150 min (30 min after cessation ofdialysis). Normal saline was infused during dialysis at a rate sufficient to replace the volume removed during dialysis ( 100 ml/h).
At each measurement period the systemic arterial pressure, pulmonary artery pressure, pulmonary artery wedge pressure, and thermodilution cardiac output (mean of three injections agreeing within 10%) were recorded. Constancy of exhaled minute ventilation was confirmed by measurement with a Collins spirometer (Warren E. Collins, Inc., Boston, MA). Venous white blood cell count (WBC) was measured by a Coulter counter (Coulter Electronics, Inc., Hialeah, FL). Arterial and mixed venous blood samples were obtained for measurement of Po2 and Pc02 (MKS Mark II blood gas analyzer; Radiometer America, Inc., Westlake, OH) and inert gas concentrations (inert gas measurements were made at the 5-min sampling period in only four dogs). During 16 dialysis measurements in six dogs, blood returning to the dog from the dialyzer was also sampled for blood gases. The rate of CO2 removal by the dialyzer was calculated as the product of the dialyzer blood flow and the CO2 content difference between blood flowing to and returning from the dialyzer. The CO2 elimination removed by dialysis was compared with the reduction in pulmonary (Vco2) from the average of the preand postdialysis Vco2. The ratio of the CO2 removed by the dialyzer to the decrease in CO2 removed by the lungs was calculated. Mixed exhaled gas was sampled and kept heated to 40°C to void condensation of soluble inert gases in water vapor. After separation on a gas chromatograph the inert gases were measured with either an electron capture detector (SF6) or a flame ionization detector ( 1).
Several parameters of ventilation-perfusion matching were obtained from the inert gas results. The data were initially converted into the retention (arterial partial pressure/mixed venous partial pressure) and excretion (partial pressure in exhaled air/mixed venous partial pressure) ratios for each inert gas. First the methods of Evans and Wagner (12) and Wagner et al. (13) were used to convert inert gas retention and excretion values into a plot of percentage oftotal perfusion and ventilation to each of 50 compartments. These compartments include inert gas shunt (VA/. = 0), inert gas dead space (VA/Q = oo), and 48 other compartments with VA/Q ranging from 0.001 to 100. The following parameters were calculated: (a) the overall mean ventilation-to-perfusion ratio for the lung, (b) the shunt flow (Qs/QT), (c) the flow to regions of low but finite VA/Q (0.001 < VA/Q < 0.1), and (d) the mean and standard deviation of the percent total perfusion (or ventilation distribution) to the 50 compartments. Shifts in the position (mean) or dispersion (standard deviation) of either the perfusion or ventilation distribution reflect changes in ventilation-perfusion matching; (e) the inert gas dead space (VD/VT) and physiological dead space are measurements of wasted ventilation. The retention and excretion data were also analyzed directly (14) to derive (f), the inert gas arterial-alveolar difference ([a-A]D) area This is calculated from the difference between the arterial and mixed expired partial pressure of each of the six inert gases plotted against inert gas solubility (14). The (a-A)D area is a measurement of the inhomogeneity of VA/Q matching after correcting for effects ofshunt and anatomical dead space; (g) the relative (a-A)D area is the fraction of the (a-A)D area up to the mean VA/Q of the lung. The relative (a-A)D area will decrease if there is a shift toward lower VA/Q regions (14) and will increase if there is a shift toward higher VA/Q regions.
Finally, (h) the alveolar-arterial Po2 difference and (i) the venous admixture were predicted from the inert gas analysis (12) . Changes in measured variables during dialysis were compared by analysis of variance and the t test (Clinfo computer program, Clinical Research Center grant RR-37).
Results
Nine dogs were studied. The first three dogs showed substantial leukopenia after the insertion of vascular catheters before starting dialysis. In the remaining dogs, such predialysis leukopenia did not occur since strict aseptic techniques were used during catheter insertion. The mean pulmonary artery pressure did not change with initiation of dialysis in these first three dogs, but it increased in the remaining dogs. Otherwise, there were no significant differences in hemodynamic or gas exchange results between the first three dogs and the subsequent six dogs. Data for all nine dogs are presented in the tables.
Hemodynamic changes (Fig. 1 , Table I ). Systolic and diastolic blood pressure fell in all dogs at the initiation of dialysis and remained decreased throughout dialysis. Cardiac output fell progressively during dialysis and increased after completion of dialysis, although it did not return to the control level. Pulmonary artery wedge pressure was unchanged. Mean pulmonary artery pressure increased promptly as soon as dialyzed blood began to return to the dogs and remained somewhat elevated throughout dialysis.
WBC counts (Fig. 2 , Table I ). In dogs 4-9, white cell counts decreased rapidly from 8,200±1,500/ml (mean±SEM) before dialysis to 2,400±200/ml within 5 min of the start of dialysis. The WBC count remained depressed during the first hour of dialysis but then rose progressively and was not different from control levels after 2 h of dialysis. A significant increase above the initial control WBC count occurred 30 min after dialysis was completed. Gas exchange (Table I ). The mean measured Po2 showed no significant changes at any point during the experiment (Fig.  3) . In three dogs, however, we noted a drop of >10 torr at the 5-or 1 5-min recordings, with a subsequent return to base line. Measured P.co2 was unchanged. Oxygen consumption did not change significantly during dialysis but there was a decrease in pulmonary CO2 exchange (Fig. 4) , which was significant at all times after 15 min of dialysis. The resulting lung respiratory exchange ratio (R) decreased from 1.02±0.03 before dialysis to 0.84±0.03 during dialysis (P < 0.001). WBC decreased, but the Po2 did not decrease. This was followed by conventional dialysis using the same membrane, and the Po2 fell, while the WBC returned to normal.
Recent clinical studies have shown that most hypoxia can be attributed to hypoventilation, but some discrepancies remain. In a careful study Patterson et al. (5) calculated a decrease in mean R from 0.81 to 0.62 in seven patients during hemodialysis. The decrease in ventilation accounted for 83% of the observed decrease in P02. Since the Pco2 and calculated alveolar-arterial Po2 difference were unchanged, they found no evidence of ventilation-perfusion mismatching. On the other hand, two studies in patients with acute renal failure show a decreased Po2 during dialysis despite constant mechanical ventilation (25, 26) . Patients with injured lungs may respond differently than those without any prior pulmonary dysfunction. The WBC agglutination and hypoventilation theories are not incompatable, and the literature suggests that both may play a role. DeBacker et al. (27) Use ofthe multiple inert gas elimination technique to quantitate pulmonary gas exchange during dialysis is especially useful because the retention and excretion analysis of the inert gases is only dependent upon inert gas solubility and pulmonary ventilation-perfusion matching and is not affected by the transfer of oxygen and carbon dioxide or inert gases at extrapulmonary sites (13) . Loss of inert gases into the dialysate will not affect the inert gas evaluation of pulmonary ventilation-perfusion matching because any peripheral exchange will not affect the mass balance of inert gases in the lung. In this experiment oxygen consumption and CO2 elimination were also measured directly.
Our results showed that during constant controlled ventilation no significant decrease in Pao2 occurred during dialysis despite the development ofprofound leukopenia. The leukopenia resolved after 2 h ofdialysis and a rebound leukocytosis occurred after cessation of dialysis.
Hemodynamic changes occurred in both the pulmonary and systemic circulations. A significant elevation in pulmonary artery pressure accompanied the severe neutropenia seen within 5 min after initiation of dialysis in the final six animals. This effect was not seen in the first three dogs, who had only an additional minor drop in leukocyte count due to low predialysis levels. Therefore, the initial pulmonary hypertension appears to be a result of the immediate hemodialysis-induced leukocyte aggregation and pulmonary sequestration. Alternatively, the pulmonary hypertension may be caused by vasoactive substances produced by the interaction of blood and dialysis membrane, as recently suggested by Walker et al. (28) . The other major hemodynamic effect of dialysis was a progressive reduction in the cardiac output. The time course of the reduced cardiac output did not correlate with the time course ofthe neutropenia, and so did not appear to be directly related to the pulmonary leukocyte aggregation. Since the dogs were infused with saline to replace the calculated volume lost during dialysis, and since the pulmonary capillary wedge pressure did not fall, the decreased cardiac output was not caused by volume depletion. The dogs were kept under uniform anesthesia, eliminating variability of depth of anesthesia as a factor. The cardiac output significantly increased after dialysis was terminated, suggesting that the procedure itself was responsible for the decrease in cardiac function. Left ventricular dysfunction has been reported to occur during dialysis (29) . One possibility is that the acetate decreases myocardial contractility (30, 31) , which causes the drop in cardiac output.
These hemodynamic changes during dialysis were not, however, associated with statistically significant changes in the matching of pulmonary ventilation and perfusion. Two aspects ofgas exchange should be noted. First, the observed trend toward an increase in dead space may reflect minor worsening in VA/ Q matching due to leukostasis. A similar increase in physiological dead space was seen in studies by Dolan et al. (20) and Patterson et al. (5) . The remaining ventilation-perfusion matching was unaltered as the decreased remaining ventilation to perfused lung was accompanied by a reduced cardiac output. Secondly, the observation that the PaCO2 did not decrease despite removal of CO2 by the dialyzer is explained by the two influences that in isolation would raise the Pco2. The first ofthese is the increase in physiological dead space; the second is the increase in mixed venous Pco2 and subsequently arterial Pco2 that occurs when cardiac output diminishes. These influences were opposed to a similar extent by the effect of dialysate removal of CO2, so that the net result was no change in PaCO2.
Several parameters obtained from the inert gas elimination technique showed no significant mismatching of ventilation to perfusion during dialysis. When the inert gas data were transformed into a 50-compartment model of ventilation-perfusion matching, the relative percent shunt and perfusion to regions of low VA/Q were unchanged. There was no change in the matching of blood flow to ventilation assessed by the standard deviation of the perfusion distribution. Direct analysis of the magnitude of the arterial-alveolar concentration differences for the inert gases showed there was no change in this measurement of ventilation-perfusion matching. Although no single parameter fully characterizes ventilation-perfusion matching, the failure ofany ofthem to change during dialysis provides strong evidence against ventilation-perfusion mismatching that would lead to hypoxemia during hemodialysis in these dogs.
Although the mean Pao2 did not change significantly in the entire group of dogs or in the last six dogs (by paired-t test), in three dogs the Pao2 fell by >10 torr at 5-15 min. Even in the three dogs with transient decrease in PaQ2 after initiation of dialysis, no ventilation-perfusion mismatch could be detected by the inert gas elimination technique. But at 5 min the dogs may not have been in a steady state, and small changes in gas exchange could have been undetected. Thus, it is possible that the aggregated leukocytes briefly caused transient hypoxia in some of the dogs. The PaO2 quickly returned to normal levels, whereas in spontaneously breathing patients the hypoxemia persists throughout dialysis (5) . If leukocyte aggregation plays a role in the hypoxia, it is only a transient one.
In summary, neither hypoxemia nor ventilation-perfusion mismatching for infused inert gases developed in dogs ventilated during a 2-h dialysis against an acetate-contained dialysate. They did demonstrate severe leukopenia, increased pulmonary artery pressure, and increased dead space. These results show that pulmonary leukocyte aggregation does not cause significant ventilation-perfusion mismatching during dialysis. Extrapolation of these results to the situation in which hypoxemia is observed in spontaneously ventilating patients during hemodialysis suggests that such hypoxemia is mainly due to pulmonary hypoventilation.
